Abdo-Cuza AA, Hall-Smith C, Suárez-López J, Castellanos-Gutiérrez R, Blanco-González MÁ, Machado-Martínez R, Pi-Ávila J, Gómez-Peire F, Espinosa-Nodarse N, López-González JC

Idioma: Ingles.
Referencias bibliográficas: 25
Paginas: 28-31
Archivo PDF: 140.82 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Varga Z, Flammer AJ, Steiger P, Haberecker M,Andermatt R, Zinkernagel AS, et al. Endothelialcell infection and endotheliitis in COVID-19.Lancet. 2020 May 2;395(10234):1417–8. DOI:10.1016/S0140-6736(20)30937-5

2. Mosleh W, Chen K, Pfau SE, Vashist A. Endotheliitisand endothelial dysfunction in patients withCOVID-19: its role in thrombosis and adverseoutcomes. J Clin Med. 2020 Jun 15;9(6):1862.DOI: 10.3390/jcm9061862

3. Baig AM, Khaleeq A, Ali U, Syeda H. Evidenceof the COVID-19 virus targeting the CNS: tissuedistribution, host-virus interaction, and proposedneurotropic mechanisms. ACS Chem Neurosci.2020 Apr 1;11(7):995–8. DOI: 10.1021/acschemneuro.0c00122

4. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al.Neurologic manifestations of hospitalized patientswith Coronavirus disease 2019 in Wuhan, China.JAMA Neurol. 2020 Jun 1;77(6):683–90. DOI:10.1001/jamaneurol.2020.1127

5. Collantes MEV, Espiritu AI, Sy MCC, AnlacanVMM, Jamora RDG. Neurological manifestationsin COVID-19 infection: a systematic reviewand meta-analysis. Can J Neurol Sci. 2021Jan;48(1):66–76. DOI: 10.1017/cjn.2020.146

6. Blanco P, Abdo-Cuza A. Transcranial Dopplerultrasound in neurocritical care. J Ultrasound.2018 Mar;21(1):1–16. DOI: 10.1007/s40477-018-0282-9

7. Wardlaw JM, Smith C, Dichgans M. Small vesseldisease: mechanisms and clinical implications.Lancet Neurol. 2019 Jul;18(7):684–96. DOI:10.1016/S1474-4422(19)30079-1

8. Markus HS, Harrison MJ. Estimation of cerebrovascularreactivity using transcranial Doppler,including the use of breath-holding as the vasodilatorystimulus. Stroke. 1992 May;23(5):668–73.DOI: 10.1161/01.str.23.5.668

9. Fierstra J, Sobczyk O, Battisti-Charbonney A,Mandell DM, Poublanc J, Crawley AP, et al. Measuringcerebrovascular reactivity: what stimulusto use? J Physiol. 2013 Dec 1;591(23):5809–21.DOI: 10.1113/jphysiol.2013.259150

10. Marinho CG, Melo HA, Salvatori R, Nunes MAP,Oliveira CRP, Campos VC, et al. Cerebral vasoreactivity,a surrogate marker of cerebrovasculardisease, is not impaired in subjects withlifetime, untreated, congenital isolated GH defi -ciency. Endocrine. 2020 Nov;70(2):388–95. DOI:10.1007/s12020-020-02415-0

11. Ju K, Zhong L, Ni X, Cao H, Cheng G, Ding L.Cerebral vasomotor reactivity predicts the developmentof acute stroke in patients with internalcarotid artery stenosis. Neurol Neurochir Pol.2018 May–Jun;52(3):374–8. DOI: 10.1016/j.pjnns.2017.12.015

12. Gaba K, Bulbulia R. Identifying asymptomaticpatients at high-risk for stroke. J Cardiovasc Surg(Torino). 2019 Jun;60(3):332–44. DOI: 10.23736/S0021-9509.19.10912-3

13. World Health Organization [Internet]. Geneva:World Health Organization; c2021. Overview.COVID-19 Clinical management: living guidance;2021 Jan 25 [cited 2021 Jul 5]. 81 p. Availableat: https://www.who.int/publications/i/item/clinical-management-of-covid-19

14. Ministry of Public Health (CU). Protocolo Cubavs COVID 4-4-2020. Havana: Finlay-AlbarránSchool of Medicine; 2020 Apr 4 [cited 2021 Jul5]. 103 p. Available at: https://instituciones.sld.cu/facultadfinlayalbarran/protocolo-cuba-vs-covid-4-4-2020. Spanish.

15. Settakis G, Lengyel A, Molnár C, Bereczki D,Csiba L, Fülesdi B. Transcranial Doppler studyof the cerebral hemodynamic changes duringbreath-holding and hyperventilation tests. J Neuroimaging.2002 Jul;12(3):252–8.

16. Staszewski J, Skrobowska E, Piusińska-Macoch R, Brodacki B, Stępień A. Cerebraland extracerebral vasoreactivity in patientswith diff erent clinical manifestations of cerebralsmall-vessel disease: data from the significance of hemodynamic and hemostaticfactors in the course of diff erent manifestationsof cerebral small-vessel disease study. JUltrasound Med. 2019 Apr;38(4):975–87. DOI:10.1002/jum.14782

17. Lavi S, Gaitini D, Milloul V, Jacob G. Impairedcerebral CO2 vasoreactivity: association withendothelial dysfunction. Am J Physiol HeartCirc Physiol. 2006 Oct;291(4):H1856–61. DOI:10.1152/ajpheart.00014.2006

18. Kozera GM, Dubaniewicz M, Zdrojewski T,Madej-Dmochowska A, Mielczarek M, WojczalJ, et al. Cerebral vasomotor reactivity and extentof white matter lesions in middle-aged men witharterial hypertension: a pilot study. Am J Hypertens.2010 Nov;23(11):1198–203. DOI: 10.1038/ajh.2010.152

19. Gladka MM, Maack C. The endothelium as Achilles’heel in COVID-19 patients. Cardiovasc Res. 2020 Dec 1;116(14):e195–e7. DOI: 10.1093/cvr/cvaa327

20. Libby P, Lüscher T. COVID-19 is, in the end,an endothelial disease. Eur Heart J. 2020 Sep1;41(32):3038–44. DOI: 10.1093/eurheartj/ehaa623

21. Sonkaya AR, Öztrk B, Karadaş Ö. Cerebralhemodynamic alterations in patients with Covid-19. Turk J Med Sci. 2021 Apr 30;51(2):435–9.DOI: 10.3906/sag-2006-203

22. Marcic M, Marcic L, Marcic B, Capkun V, VukojevicK. Cerebral vasoreactivity evaluated bytranscranial color Doppler and breath-holdingtest in patients after SARS-CoV-2 infection. JPers Med. 2021 May 6;11(5):379. DOI: 10.3390/jpm11050379

23. Wardlaw JM, Smith C, Dichgans M. Small vesseldisease: mechanisms and clinical implications.Lancet Neurol. 2019 Jul;18(7):684–96. DOI:10.1016/S1474-4422(19)30079-1

24. Tallon CM, Barker AR, Nowak-Flück D, AinsliePN, McManus AM. The infl uence of age andsex on cerebrovascular reactivity and ventilatoryresponse to hypercapnia in children and adults.Exp Physiol. 2020 Jul 1;105(7):1090–1101. DOI:10.1113/EP088293

25. Mousavi SA, Khourvash F, Asadi B, KarkheiranF. Evaluation of vasomotor reactivity bytranscranial Doppler sonography: age and sexrelated diff erences in breath holding index inIranian population. J Res Medical Sci. 2005Mar;10(2):93–6.